Outcome of Wingspan Stent Using Aggressive Post-stent Balloon Dilation for Intracranial Atherosclerosis Stenosis

Pang-Shuo Perng1, Yuan-Ting Sun2,3, Hao-Kuang Wang4,5

  • 1Division of Neurosurgery, Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

Frontiers in Neurology
|November 11, 2021
PubMed

Insights

Post-dilation after Wingspan stenting for intracranial atherosclerosis disease (ICAD) significantly reduces in-stent restenosis. This technique improves stent expansion and may prevent neurological events in ICAD patients.

Area of Science:

  • Interventional Neurology
  • Vascular Surgery
  • Medical Devices

Background:

  • Intracranial atherosclerosis disease (ICAD) poses a risk for neurological events.
  • Wingspan stent is used for ICAD, but in-stent restenosis remains a challenge.
  • Preventing in-stent restenosis is crucial for improving long-term outcomes.

Purpose of the Study:

  • To evaluate the efficacy of post-dilation in preventing in-stent restenosis after Wingspan stenting in ICAD patients.
  • To compare outcomes between patients with and without post-dilation.

Main Methods:

  • Retrospective review of 28 ICAD patients (>70% stenosis) treated with Wingspan stent.
  • Patients divided into two groups: post-dilation (n=15) and no post-dilation (n=13).
  • Comparison of stenosis extent, stent diameter, and luminal diameter at immediate post-surgery and 1-year follow-up.

Main Results:

  • Post-dilation group showed significantly lower stenosis immediately (14.8% vs 28.5%) and at 1-year (25.8% vs 50.1%).
  • Post-dilation improved immediate stent expansion and maintained luminal diameter at 1-year, unlike the no post-dilation group.
  • Periprocedural complication rates were similar between groups.

Conclusions:

  • Post-dilation is a feasible technique for Wingspan stenting in ICAD.
  • It enhances stent expansion and apposition, potentially preventing in-stent restenosis.
  • This method may lead to improved neurological outcomes for ICAD patients.